Search

everythinglearnresearchcommunity

for

Search:↓

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Using minoxidil with laser therapy is more effective for female hair loss than minoxidil alone.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The authors suggest that scalp hair might protect against COVID-19 and call for more research on scalp health and the virus.

Early treatment of traction alopecia can reverse hair loss; prevention involves avoiding tight hairstyles.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

ALRN-6924 may prevent hair loss caused by chemotherapy.

A bald man grew hair on his head after taking a drug called diazoxide, but lost it again when he stopped the medication.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

Baldness is common in Korean men (60.5%), and those with a family history are 3.1 times more likely to have hairline recession.

Treatments for hair loss vary, but cell-based options may be the future.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

PRP injections improve hair density in male hair loss.

New hair transplant method allows for hair regrowth in the donor area and less scarring.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

CTE can distort results in hair growth trials, so exclude it carefully.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Red and infrared light therapy improves hair growth in balding patients.

Hair transplantation techniques have improved over time, leading to natural-looking results and high graft survival rates, making it a popular treatment for hair loss.